831
Participants
Start Date
February 17, 2012
Primary Completion Date
February 6, 2016
Study Completion Date
August 17, 2017
Ipilimumab
Local Institution, Lausanne
Local Institution, Vienna
Fundacion Cidea, Buenos Aires
Local Institution, Budapest
Local Institution, Brussels
Local Institution, Camperdown
Local Institution, Coffs Harbour
Local Institution, Herlev
Local Institution, Leuven
Local Institution, Heidelberg
Local Institution, San Miguel de Tucumán
Local Institution, Linz
Local Institution, Brisbane
Local Institution, Southport
Local Institution, Adelaide
Local Institution, Odense
Local Institution, Bergen
Local Institution, George
Local Institution, Szeged
Local Institution, Kaposvár
Local Institution, Cape Town
Local Institution, Rondebosch
Local Institution, Aarhus
Memorial Sloan Kettering Cancer Center, New York
Local Institution, Marseille
St. Luke's Cancer Center - Anderson Campus, Easton
Local Institution, Milan
Local Institution, Dijon
Local Institution, Buxtehude
Local Institution, Kiel
Duke University Hospital, Durham
Local Institution, Madrid
Levine Cancer Institute, Charlotte
Local Institution, Hanover
Local Institution, Navarra
Local Institution, Toulouse
Baptist Cancer Institute, Jacksonville
Orlando Health, Inc, Orlando
Local Institution, Bordeaux
Local Institution, Padua
Local Institution, Leon, Guanajato
Local Institution, Grenoble
Local Institution, Nantes
Local Institution, Essen
Instituto Valenciano De Oncologia, Valencia
Local Institution, Valencia
Local Institution, Meldola (fc)
Local Institution, Reims
Local Institution, Siena
Local Institution, Mainz
Local Institution, Lille
Oncology Specialists, S.C., Park Ridge
Local Institution, Heidelberg
Local Institution, Pierre-Bénite
Local Institution, Jerusalem
Local Institution, Tübingen
Local Institution, Paris
Local Institution, Napoli
Local Institution, Munich
The Angeles Clinic And Research Institute, Los Angeles
University Of California Los Angeles, Los Angeles
Local Institution, Villejuif
Providence Portland Medical Center, Portland
Seattle Cancer Care Alliance, Seattle
Local Institution, Edmonton
Local Institution, Halfax
Local Institution, Montreal
Local Institution, Brno
Local Institution, Olomouc
Local Institution, Prague
Local Institution, Roma
Local Institution, Amsterdam
Local Institution, Groningen
Local Institution, Leiden
Local Institution, Oslo
Local Institution, Gdansk
Local Institution, Poznan
Local Institution, Warsaw
Local Institution, Barcelona
Local Institution, Barcelona
Local Institution, Gothenberg
Local Institution, Lund
Local Institution, Stockholm
Local Institution, Umeå
Local Institution, Manchester
Local Institution, Glasgow, Scotland
Local Institution, London
Local Institution, Swansea
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY